Baker Bros. Advisors Lp Bicycle Therapeutics PLC (BCYC) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded
Dec 16 2024	BUY Open market or private purchase	$7,670,000 $15.34 p/Share	500,000
Dec 13 2024	BUY Open market or private purchase	$13,460,523 $13.66 p/Share	985,397
Jun 17 2024	BUY Conversion of derivative security	-	2,382,784
Apr 18 2024	BUY Grant, award, or other acquisition	-	24,000

Also insider at

INCY

INCYTE CORP Healthcare

GHDX

GENOMIC HEALTH INC

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

BLCM

BELLICUM PHARMACEUTICALS, INC Healthcare

> 10% Shareholder

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

KOD

Kodiak Sciences Inc. Healthcare

HOOK

HOOKIPA Pharma Inc. Healthcare

BCEL

Atreca, Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

IMCR

Immunocore Holdings plc Healthcare

BBA